|
Therapeutic Category |
|
Anti-Diabetic |
|
Generic Name |
|
Glibenclamide+Metformin HCl |
|
Indications |
|
It is indicated as an adjunct to diet and exercise to improve glycemic control in patient with type 2 diabetes whose diabetes is not adequately controlled with Glibenclamide or Metformin HCl alone, or for those patients who have initially responded to Glibenclamide or Metformin HCl alone and require additional glycemic control.
|
|
Brand Name |
|
Metcon/ Metcon Plus |
|
Dosage Form |
|
Tablets |
|
Strength |
|
500+2.50 mg/
500+5 mg |
|
Market Availability |
|
Pakistan, Uzbekistan, Kenya |
|
Presentation |
|
Alu-PVC blister of 30’s |
|
|
|